Werewolf Therapeutics, Inc. financial data

Symbol
HOWL on Nasdaq
Location
200 Talcott Avenue, 2 Nd Floor, Watertown, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 597 % -29.3%
Debt-to-equity 101 % +91.3%
Return On Equity -144 % -145%
Return On Assets -71.7 % -86.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.5M shares +8.93%
Common Stock, Shares, Outstanding 47.3M shares +8.12%
Entity Public Float 69.7M USD +3.47%
Common Stock, Value, Issued 5K USD +25%
Weighted Average Number of Shares Outstanding, Basic 45.8M shares +4.8%
Weighted Average Number of Shares Outstanding, Diluted 45.8M shares +4.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 53.6M USD +6.49%
General and Administrative Expense 18M USD -6.52%
Operating Income (Loss) -71.6M USD -8.16%
Nonoperating Income (Expense) -1.23M USD -130%
Net Income (Loss) Attributable to Parent -72.8M USD -17.3%
Earnings Per Share, Basic -1 USD/shares -7.29%
Earnings Per Share, Diluted -1 USD/shares -3.25%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 65.7M USD -46.5%
Assets, Current 68.2M USD -45.8%
Property, Plant and Equipment, Net 5.09M USD -24.8%
Operating Lease, Right-of-Use Asset 5.42M USD -12.2%
Other Assets, Noncurrent 46K USD +9.52%
Assets 79.6M USD -43.1%
Accounts Payable, Current 1.08M USD -13.1%
Employee-related Liabilities, Current 2.89M USD +3.04%
Accrued Liabilities, Current 9.02M USD -8.92%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 17.6M USD +41.2%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 8.14M USD -17.3%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 50M USD -1.27%
Retained Earnings (Accumulated Deficit) -467M USD -18.5%
Stockholders' Equity Attributable to Parent 29.6M USD -66.9%
Liabilities and Equity 79.6M USD -43.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.9M USD -23.9%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 47.3M shares +8.12%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -18.9M USD -491%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 66.6M USD -46.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 773K USD -15.1%
Deferred Tax Assets, Valuation Allowance 67.8M USD +44%
Deferred Tax Assets, Gross 70.3M USD +39.9%
Operating Lease, Liability 11M USD -12.8%
Depreciation 426K USD -8.19%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 13.5M USD -15.7%
Property, Plant and Equipment, Gross 11.3M USD +1.6%
Operating Lease, Liability, Current 1.5M USD +13.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.4M USD +2.82%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.34M USD -6.71%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.48M USD -26.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.47M USD +2.83%
Deferred Tax Assets, Operating Loss Carryforwards 32.8M USD +37.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.54M USD +2.87%
Additional Paid in Capital 497M USD +2.7%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 2.57M USD -19.7%
Share-based Payment Arrangement, Expense 6.94M USD -21.1%
Interest Expense 1M USD +483%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%